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PREDICTORS OF HOSPITALIZATION AND 
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OBJECTIVE: To develop a predictive risk-assessment
model for asthmatics of a Medicaid managed care popu-
lation using claims data. The model weighs the predictive
value of commonly collected variables to identify mem-
bers at risk for hospitalizations and emergency room uti-
lization. METHODS: For this retrospective cohort study,
asthmatics continuously enrolled from January 1, 1998
through December 31, 1998 were identified. Asthmatics
were defined as members with: (1) at least one medical
claim with an ICD-9 code (493.00–493.9) for asthma
(between 18–65 years of age) or (2) at least one prescrip-
tion for any asthma-related drug for patients between
18–44 years of age. Patients receiving beta2-agonists must
have had at least 2 prescriptions during the 1-year study
period. Patients were defined as high- or low-risk based
on asthma-related resource use for a 6-month period
(7/1/98–12/31/98). Claims from the prior six months
were used to obtain predictive variables. A multivariate
predictive model was developed using classification and
regression tree analyses. RESULTS: We identified 5299
asthmatics of which 13% (694/5299) were classified as
high-risk. The model identified high-risk patients with a
sensitivity 91%, specificity 27%, positive predictive value
30%. We assigned a higher weight for misclassifying
high-risk verses low-risk recipients. The sensitivity of the
model outperformed individual predictive variables with
the exception of primary care visits. Variables identified
as having relative importance include (in order of impor-
tance): ER utilization, hospitalizations, number of oral
steroid prescriptions, number of asthma prescriptions,
and number of primary care visits. CONCLUSION: We
conclude that claims data can identify high-risk patients
with a high sensitivity, so as to allow for timely interven-
tion. The limitation, however, is poor specificity.
PRS10
ANNUAL COST OF TREATING ASTHMA IN A 
MANAGED CARE POPULATION
Yazdani C1, Stanford R2, McLaughlin T1, Margraf T3
1NDC Health Information Services, Phoenix, AZ, USA; 2Glaxo 
Wellcome Inc, Research Triangle Park, NC, USA; 3PharMetrics, 
Inc., Boston, MA, USA
OBJECTIVE: To determine the average annual cost of
treating asthma in a managed care population. METH-
ODS: All subjects contained within Pharmetric’s Inte-
grated Outcomes database possessing a diagnosis of
asthma (ICD-9-CM  493) during 1996–1998 were eli-
gible for study inclusion. Patients were required to have
12 months of data following the first (index) asthma di-
agnosis present. Patients with the diagnosis of chronic
obstructive pulmonary disease and coronary failure were
excluded. Asthma specific and total medical charges were
captured for the study period, as well as asthma-related
and general hospitalizations. Charges, hospitalization
and emergency department (ED) visit rates were com-
pared across age categories (6–17, 18–44, 45) and gen-
der. RESULTS: 77,603 patients met the inclusion crite-
ria. The mean age was 30.9 years (SE  0.061), and
60.6% of the sample was female. The mean annual
asthma specific charges per patient was $926.68 (SE 
9.59). Inpatient charges accounted for 48.9% of asthma-
related expenses, while outpatient and pharmacy charges
accounted for 25.0% and 24.6% respectively. Asthma-
related costs increased with age (6–17: $683.61; 18–44:
$962.24; 45: $1177.80). 10.0% of the identified pa-
tients were hospitalized for asthma within 12 months of
index diagnosis. The rate of asthma-related hospitaliza-
tion was similar across the three age categories. In addi-
tion, 5.3% of patients visited the ED due to asthma exac-
erbation during the 12 months of observation, with the
rate of ED visits decreasing with age (6–17: 6.11%; 18–44:
5.87%; 45: 3.45%). CONCLUSION: A substantial
portion of asthmatics in this study required inpatient or
emergency room care related to an asthma exacerbation.
As hospitalization for asthma is often considered an
avoidable outcome, these results point to the inadequa-
cies of current preventive asthma treatment.
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OBJECTIVE: The objective of this study was to describe
the inpatient procedural medical care utilization the first
ten years after initial inpatient confirmation of peripheral
arterial disease (PAD). METHODS: We performed a ret-
rospective review of the computer records of all the bene-
ficiaries of the Department of Defense health care system
since 1970. Over 8000 subjects with an initial inpatient
confirmation of PAD between 1/1/80 and 12/31/85 were-
reviewed for ten years following the initial visit. RE-
SULTS: The utilization of PAD-related invasive proce-
dures gradually increased over the first eight years, and
rose sharply in the 9th, and 10th years after initial diagno-
sis. The utilization of examination procedures was high-
est in the 1st, 5th–7th, 9th and 10th years. Procedures involv-
ing bypass and amputation had the highest utilization
among invasive procedures, while procedures involving
arteriography and ultrasonography accounted for 89%
